Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
5
×
clinical trials
life sciences
national blog main
boston
fda
national top stories
biotech ipos
ipo
medical device
multiple myeloma
national
non-hodgkin lymphoma
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
renaissance capital
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
480 biomedical
abbvie
actavalon
acute myeloid leukemia
aileron therapeutics
ally bridge group
antibiotics
aprea therapeutics
arimoclomol
arnold levine
arsenal medical
arvinas
astrazeneca
baker brothers
big data analytics
blackrock
bob langer
What
company
5
×
ipo
5
×
developing
million
raised
biotech
drug
firms
genetic
life
medicines
new
public
raises
science
tests
therapeutics
way
analysis
bio
biotechs
blood
bring
brings
broader
cancer
chose
close
debut
detect
develop
device
diseases
disorders
dyne
dyne’s
employing
files
goldfinch
grail
Language
unset
Current search:
ipo
×
company
×
" boston top stories "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way